Search Tag: aerosolised

ICU Management

Phase-iii-study-program-with-amikacin-inhale-in-patients-with-gram-negative-pneumonia-results

2017 28 Nov

Phase III study program with Amikacin Inhale in addition to standard of care in intubated and mechanically ventilated patients with Gram-negative pneumonia does not meet primary endpoint of superiority Bayer announced on 24 November 2017 that INHALE, a global Phase III clinical study program investigating Amikacin Inhale in addition to standard of...Read more